NCT03722290View on ClinicalTrials.gov

Metformin in Children and Adults With Fragile X Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

October 24, 2019

Study Completion Date

November 1, 2020

Conditions
Fragile X Syndrome
Interventions
DRUG

Metformin

Oral administration of metformin 250mg (twice a day) for the 1st week followed by metformin 500mg (twice a day) for the next 8 weeks.

Trial Locations (1)

J1H 5H3

Université de Sherbrooke, Sherbrooke

Sponsors

Collaborators (1)

FRAXA Research Foundation
All Listed Sponsors
collaborator

FRAXA Research Foundation

OTHER

lead

Université de Sherbrooke

OTHER